Randomized clinical trials--removing unnecessary obstacles.
about
Why Most Clinical Research Is Not UsefulRandomized controlled trials - a matter of designPractice-based Research Networks (PBRNs) in the Era of Integrated Delivery SystemsEbola: a holistic approach is required to achieve effective management and controlPractical clinical trials in psychopharmacology: a systematic reviewKey cost drivers of pharmaceutical clinical trials in the United StatesIncreasing value and reducing waste in biomedical research regulation and managementAre Research Ethics Committees Prepared for Community-Based Participatory Research?Data fraud in clinical trials.Comparative costs and activity from a sample of UK clinical trials units.The recording of adverse events from psychological treatments in clinical trials: evidence from a review of NIHR-funded trials.Clinical trials in crisis: Four simple methodologic fixes.Clinical research and medical care: towards effective and complete integrationCreating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program"You can't always get what you want": from doctrine to practicability of study designs for clinical investigation in endometriosis.Generating evidence on a risk-based monitoring approach in the academic setting - lessons learnedA pilot test of the new Swiss regulatory procedure for categorizing clinical trials by risk: A randomized controlled trial.The impact of data errors on the outcome of randomized clinical trials.Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds.Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).Barriers to the conduct of randomised clinical trials within all disease areas.Improving public health by improving clinical trial guidelines and their application.Registry-based randomized clinical trials--a new clinical trial paradigm.Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary.Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology.Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.Early Vision for the CTSA Program Trial Innovation Network: A Perspective from the National Center for Advancing Translational Sciences.Regulation and governance of multinational drug trials in stroke: barriers and possibilities.Truths, lies, and statistics.What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis.Glomerular Diseases: Registries and Clinical Trials.A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.Design and conduct of a provider survey to determine a clinically persuasive effect size in planning VA Cooperative Study #590 (Li+).
P2860
Q24707972-EB2A6E65-66E7-49E2-BF72-4ACA933D04C9Q26746217-382D0DF1-24F7-4FDF-BF3C-576824619A3FQ26782041-5731F5D4-8F15-4225-83B5-EC29BEB7F80CQ26823792-3F858D98-B771-454C-A7CF-2E2D62E47880Q27021467-E8123D46-C6F6-4C91-AC34-D7967A20F3E4Q28273573-600A243E-491D-41A4-A972-5287A8684C2BQ28657841-04E89C19-CF8B-4A45-8E95-FD06B0A7EB9CQ30202199-60EA095E-F53C-44D2-BA88-C833C68B6A0DQ30902176-48C26F59-AEEC-49A5-B8CA-878AC78F5713Q33629954-7EBE4451-DFC6-4BCA-8BF7-73C06A3089D0Q34123552-BDBEDDD6-79D5-4D96-9683-008E7A6382B2Q34498710-2E7A8CE2-BDC9-4C20-B14E-9B1F6650D290Q35068463-88F52951-8D1E-41D0-BC84-7DE81AA15FC7Q35572502-4B2CEA74-BF6F-4F6F-B711-43FD4002E7F5Q35816710-0621D8C9-4F48-4595-A3ED-7772837950B5Q36279006-53A8DD50-B0DB-4D32-B85B-F07ED6394C7BQ36288020-0E927DE6-6FF4-4D3C-B2CD-AD79B9D98326Q36412734-C785C5A8-527A-402F-BF25-93D6F52712F2Q36650748-C5320CC7-C996-41F0-94B0-CC6FF2E65F9DQ37002683-98708409-F736-4C41-BA35-F002ADEBB434Q38369293-CDEE8788-C3BE-4905-BB53-3029CA8E7C8BQ38372022-BBAFFC6B-7AAC-43F7-91B7-DE1BF140A6BAQ38381408-9A6F85C1-8770-4303-8C39-A6B83999CB85Q38526979-8F7A3427-FFBC-4D03-B9FB-B8DB5E2FFFBBQ38528288-2460BF6F-E72E-403B-9EBA-3560044E082BQ38635306-C342BA56-39F9-494D-A356-39EC56440F98Q41369457-881F2956-C30F-4BA8-9055-A01D5D654D91Q41593834-66B17F20-D1F4-47B1-9676-5C3BBB9B1F74Q47108688-422D0832-661E-4CA1-B9CA-173FD001ECC6Q47196150-F6F061E8-9312-4174-99E6-5B393FD859A7Q49966627-FFBBF920-651C-4130-A134-EAB0E14F2E62Q50281347-3DD91037-CFA1-4222-B1A2-F8D59451CB12Q55023653-0FBDC927-DA4A-45AE-8CE4-547ADBD91550Q55039940-79309A82-87DF-4B51-AA27-522AF4128C10
P2860
Randomized clinical trials--removing unnecessary obstacles.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Randomized clinical trials--removing unnecessary obstacles.
@en
Randomized clinical trials--removing unnecessary obstacles.
@nl
type
label
Randomized clinical trials--removing unnecessary obstacles.
@en
Randomized clinical trials--removing unnecessary obstacles.
@nl
prefLabel
Randomized clinical trials--removing unnecessary obstacles.
@en
Randomized clinical trials--removing unnecessary obstacles.
@nl
P2093
P50
P356
P1476
Randomized clinical trials--removing unnecessary obstacles.
@en
P2093
Christina Reith
Colin Baigent
Jackie Bosch
P J Devereaux
Rory Collins
P304
P356
10.1056/NEJMSB1300760
P407
P577
2013-09-01T00:00:00Z